BABA vs LAB · P/E 20, rev $137.30B vs rev $174.4M
Alibaba Group Holding Ltd (BABA) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Alibaba Group Holding Ltd (BABA) is a internet retail company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported BABA revenue for 2025-03-31 was $137.30B. Net income was $17.93B. Revenue was up 5.3% from 2024-03-31 to 2025-03-31. BABA currently screens at market cap $305.19B and trailing P/E 19.6.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
BABA currently screens at market cap $305.19B and trailing P/E 19.6. LAB currently screens at market cap $317.1M.
Not investment advice. Open the BABA and LAB stock pages for the full models.
Not investment advice.